Close
Enter your
text here
Home > clinical trial

clinical trial

I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome
 I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome 1080 608 Mireia Córcoles
By:
The Phase IIa study will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with FXS, the most common form of inherited intellectual disability without a specific treatment read more
New therapy to avoid chemotherapy in lung cancer
 New therapy to avoid chemotherapy in lung cancer 1080 607 Mireia Córcoles
By:
The results of a trial, with the participation of the I3PT, demonstrate the effectiveness of a new treatment that combines two immunotherapy drugs in patients with metastatic lung cancer read more
Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.